Phase II study of everolimus in refractory testicular germ cell tumors. [electronic resource]
Producer: 20161213Description: 122.e17-22 p. digitalISSN:- 1873-2496
- Adult
- Antineoplastic Agents -- therapeutic use
- Drug Resistance, Neoplasm -- drug effects
- Everolimus -- therapeutic use
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Neoplasm Staging
- Neoplasms, Germ Cell and Embryonal -- drug therapy
- Prognosis
- Salvage Therapy
- Survival Rate
- Testicular Neoplasms -- drug therapy
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.